- Home
- NEOV vs GNFT Comparison
NEOV vs GNFT Comparison
Compare NEOV & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- GNFT
- Stock Information
- Founded
- NEOV 2018
- GNFT 1999
- Country
- NEOV United States
- GNFT France
- Employees
- NEOV N/A
- GNFT 180
- Industry
- NEOV Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEOV Miscellaneous
- GNFT Health Care
- Exchange
- NEOV Nasdaq
- GNFT Nasdaq
- Market Cap
- NEOV 72.2M
- GNFT 186.3M
- IPO Year
- NEOV N/A
- GNFT 2019
- Fundamental
- Price
- NEOV $3.44
- GNFT $3.66
- Analyst Decision
- NEOV Strong Buy
- GNFT Strong Buy
- Analyst Count
- NEOV 1
- GNFT 1
- Target Price
- NEOV $7.50
- GNFT $13.00
- AVG Volume (30 Days)
- NEOV 146.9K
- GNFT 4.2K
- Earning Date
- NEOV 05-09-2025
- GNFT 04-24-2025
- Dividend Yield
- NEOV N/A
- GNFT N/A
- EPS Growth
- NEOV N/A
- GNFT N/A
- EPS
- NEOV N/A
- GNFT 0.03
- Revenue
- NEOV $4,255,136.00
- GNFT $73,187,701.00
- Revenue This Year
- NEOV $208.50
- GNFT $15.98
- Revenue Next Year
- NEOV $128.75
- GNFT N/A
- P/E Ratio
- NEOV N/A
- GNFT $120.95
- Revenue Growth
- NEOV 52.64
- GNFT 105.01
- 52 Week Low
- NEOV $1.80
- GNFT $2.55
- 52 Week High
- NEOV $6.11
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- NEOV 57.71
- GNFT 40.81
- Support Level
- NEOV $3.10
- GNFT $3.61
- Resistance Level
- NEOV $3.57
- GNFT $3.95
- Average True Range (ATR)
- NEOV 0.28
- GNFT 0.14
- MACD
- NEOV 0.03
- GNFT -0.02
- Stochastic Oscillator
- NEOV 75.29
- GNFT 18.06
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.